3 reports

  • Pipeline analysis
  • Vendor landscape

Out of this, ##, ## are affected by heart attack for the first time and ##, ## people have already had a heart attack.

  • Cardiovascular Disease
  • Heart Attack
  • AstraZeneca PLC
  • CicloMulsion AG
  • NSTEMI group
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Cardiovascular Disease
  • Heart Attack
  • World
  • Product Initiative
  • Aurobindo Pharma Limited
  • JUN 01, 2015: NEUROVIVE REPORTS TOPLINE RESULTS OF PHASE III CIRCUS STUDY IN ACUTE MYOCARDIAL INFARCTION
  • MAY 25, 2015: NEUROVIVE PHARMACEUTICAL: TOPLINE RESULT OF PHASE III STUDY OF CICLOMULSION IN ACUTE MYOCARDIAL INFARCTION EXPECTED THIS QUARTER

RESEARCH INTO CICLOMULSION S EFFICACY BEYOND THE TREATMENT OF REPERFUSION INJURY FOLLOWING HEART ATTACK GREW OUT OF THE CONCEPT OF MITOCHONDRIAL PROTECTION IN CONNECTION WITH ORGAN INJURY FOCUSING ON HEART DISEASE.

  • Heart Attack
  • Therapy
  • World
  • Product Initiative
  • CicloMulsion AG